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Your Best Shot at Surviving the Flu Season
Isabella Liu
Abstract: Millions of individuals become ill from the influenza virus every year. As an existing public health issue, it is important for patients to understand
that the best way to combat the influenza virus is through prevention. This article explores key aspects of the influenza vaccine and highlights its importance
in the healthcare community.

T

he Centers for Disease Control and Prevention estimates that
about 49 million individuals in the United States were ill with
the influenza virus during the 2017-2018 influenza
season.1 Influenza viruses A and B are mostly responsible for
causing seasonal influenza outbreaks.2 In addition to seasonal
illness, the influenza virus can often cause secondary
complications, hospitalizations, and deaths. The first reliable
documented record of an influenza-like disease dates back to the
year 1510. In the centuries following, multiple influenza epidemics
occurred, affecting many different continents.3 An example of a
widespread epidemic was the “Spanish” influenza pandemic of
1918. It was one of the deadliest outbreaks, affecting about onethird of the global population and caused an estimated 21 million
deaths.4 However, a breakthrough in the treatment of influenza
occurred in 1938 when Jonas Salk and Thomas Francis developed
the first influenza vaccine.3 The influenza vaccine is still the best
protection currently available against the influenza virus.

Influenza viruses A and B are most likely to cause annual,
seasonal outbreaks, with influenza virus A being most known for
drastically morphing and causing pandemics. Additionally,
influenza virus C is generally mild while influenza virus D is
prominent in cattle.7 Virus composition includes two main
surface glycoproteins that are called hemagglutinin and
neuraminidase. Changes in these glycoproteins are responsible
for changes in annual influenza season outbreaks and can cause
pandemics. The first type of change is called antigenic drift which
occurs when there are small mutations in the surface
glycoproteins. These small changes are the reason why different
strains are responsible for each influenza season. The second
type of change, which is called antigenic shift, is a major and
abrupt change in the glycoproteins which results in
pandemics. Antigenic shift most commonly occurs with influenza
virus A. The most recent pandemic caused by antigenic shift in
the United States was in 2009 with the H1N1 emergence.8

Seasonal outbreaks of the influenza virus cause millions of
individuals to fall ill. This respiratory virus is extremely contagious
and can infect the nose, throat, and lungs. Symptoms include
coughing and disruption of the upper respiratory tract, fever,
muscle aches, headaches, and fatigue.5 Transmission of the
influenza virus can be grouped into two categories: acquisition by
large droplets and acquisition by smaller, aerosol particles. Both
large droplets and small particles may be transmitted through
contact with particles from affected individuals who cough or
sneeze. Transmission by small aerosol particles tends to be longer
reaching since these particles are lightweight and can travel longer
distances, while acquisition of the illness by large droplets is
limited to close interactions.6

Today, the influenza vaccine is the best chance at preventing
influenza contraction and lessening the severity of the illness if
an individual does become infected.5 Vaccines are generally
administered via injection or nasal spray. The nasal spray
contains the live attenuated version of the virus while the
injection is inactivated. Both types cause an immune response to
the disease, in which the body produces antibodies and develops
immunity,
making
it
less
likely
to
contract
influenza. Furthermore, if a vaccinated person does become ill,
they already have antibodies from the vaccine exposure that
allow the body to fight the disease more effectively.9 It is
important to note that the influenza season begins in the fall of
one year and continues into the spring of the following year. The
influenza vaccination should be received in the beginning of the
influenza season for maximum effectiveness, since it takes
around two weeks after administration for antibodies to
develop.5

Once infected by the influenza virus, the average incubation period
is 2 days. Individuals with influenza are most contagious during the
first 3 and 4 days of getting sick.5 However, individuals with the
influenza virus can spread it 24 hours before the onset of
symptoms up to 5-7 days of having the illness. Most otherwise
healthy individuals are symptomatic for 5-7 days.5 In the case of
special populations, such as children and/or immunocompromised
individuals, symptoms can last longer than the typical time frame.
Consequently, such individuals will continue to be contagious as
the illness persists.5 Ultimately, the influenza virus’s rapid
transmission from person to person leads to widespread outbreaks
during the influenza season.
The antigenic composition of the influenza virus plays a large role
in the virus’s ability to infect humans and animals. There are four
different types of influenza viruses, which include: A, B, C, and D.

As discussed earlier, the influenza virus mutates at a quick
rate. Therefore, new influenza vaccinations are created for every
influenza season. New vaccinations are necessary to target new
variations in the influenza virus. Experts create the influenza
vaccine about six months prior to the start of the influenza
season. They determine which strains the influenza vaccine
should encompass based on global data from the previous
influenza season. Trivalent and quadrivalent influenza
vaccinations are offered. The trivalent vaccine is composed of
two strains of virus A antigens and one strain of virus B antigens.
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Similarly, the quadrivalent vaccine is composed of two strains of
virus A antigens but also contains two strains of virus B antigens.2
After experts predict the more common strains for the upcoming
season, the World Health Organization releases information
annually on their website regarding the current vaccines, including
the specific strains.
It is important to understand the indications and possible
exceptions to the influenza vaccination. Individuals including
children older than 6 months, healthy adults, the elderly, and those
immunocompromised should receive the influenza vaccine every
year.2 Children up to age 8 who have not previously received the
influenza vaccine need 2 doses, given 4 weeks apart. Children who
have previously received the influenza vaccine can receive one,
single dose.2 It is important to note that children and individuals
65 years and older are most susceptible to contracting influenza.
Those who are 65 years and older have the largest disease burden,
with an estimated 70% to 85% of deaths and 50% to 70% of
hospitalizations due to influenza. There are two types of
inactivated vaccine injections specifically approved for this
population, the High Dose Flu Vaccine and Adjuvanted Flu Vaccine.
Both invoke a greater immune response compared to the other
influenza vaccines. The High Dose Flu Vaccine contains four times
the antigen of a single dose while the Adjuvanted Flu Vaccine
contains an additive that creates a stronger immune response.
Aluminum salts or oil in water emulsions are the ingredients often
added to the Adjuvanted Flu Vaccine.10

at cases of influenza-related medical visits, hospitalizations, and
deaths. In the 2017-2018 influenza season, the U.S. had an
estimated 49 million people who were symptomatic, 23 million
people who scheduled a medical visit, 960,000 people who were
hospitalized, and 79,000 people who died from the influenza
virus.1 Due to the widespread impact of the influenza virus, it is
important for individuals to receive the influenza vaccination
annually. Not only does the vaccine decrease a person’s odds of
becoming ill with influenza, but it also helps decrease the severity
of the disease. This may be crucial in highly susceptible
populations such as children, immunocompromised individuals,
and the elderly. Ultimately, it is the responsibility of all
healthcare providers to educate patients on the severity of the
seasonal influenza and to advocate for individuals to get their
influenza vaccine.
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In regard to expecting mothers, the Centers for Disease Control
and Prevention emphasizes that it is safe for pregnant women to
get the influenza vaccine. Not only will the vaccine protect the
mother, but the mother will pass on the antibodies created by her
immune system to the baby. As far as immunocompromised
individuals, the Advisory Committee on Immunization Practices
(ACIP) recognizes that the immunogenicity of influenza is lower in
this patient population. However, the vaccine will still significantly
protect immunocompromised individuals against the virus. It is
recommended that they receive the inactivated injection, not the
attenuated live nasal vaccine.2 Other people who should avoid the
nasal spray vaccine include caregivers of or those in close contact
with immunocompromised individuals, pregnant women, children
less than 2 years old, children 2-17 years old who are also taking
aspirin, children 2-4 years old with asthma, or adults 50 years and
older.5 These individuals should receive the inactivated injection
instead. Individuals with egg allergies can receive the vaccine as
well. Those with a history of a severe allergic reaction to eggs with
symptoms other than hives should receive the vaccine in an
inpatient or outpatient medical setting, under the supervision of a
licensed medical professional who can take further action if
necessary. However, if the individual previously had an allergic
reaction to the influenza vaccine, future egg-based vaccines are
contraindicated.11 Cell-based flu vaccines are available as an
alternative because it is not created with eggs.11
Overall, the influenza vaccine has proven to lessen the influenza
burden of the world’s population. According to the World Health
Organization, annual influenza epidemics affect 3 to 5 million
people globally.13 The Centers for Disease Control and Prevention
measures the effect of influenza on the U.S. population by looking
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